Results of the ordinary and extraordinary shareholders meeting 2018
Cassiopea SpA, a clinical stage specialty pharmaceutical company focused on developing innovative and differentiated medical dermatology products, announces the results of the 2018 annual ordinary shareholders meeting as well as of the extraordinary shareholder meeting held today in Lainate, Milan (Italy). About 53,2% of Cassiopea’s total capital of 10,000,000 shares were represented at the meetings.